Turn Research Development from 2010 to 2026

TTRX Stock   4.65  0.08  1.75%   
Turn Therapeutics Research Development yearly trend continues to be fairly stable with very little volatility. Research Development is likely to outpace its year average in 2026. During the period from 2010 to 2026, Turn Therapeutics Research Development regression line of annual values had r-squared of  0.44 and arithmetic mean of  54,753. View All Fundamentals
 
Research Development  
First Reported
2010-12-31
Previous Quarter
282.8 K
Current Value
297 K
Quarterly Volatility
105.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Turn Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Turn Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 24.5 K, Interest Income of 24.5 K or Depreciation And Amortization of 50.3 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0. Turn financial statements analysis is a perfect complement when working with Turn Therapeutics Valuation or Volatility modules.
Check out the analysis of Turn Therapeutics Correlation against competitors.

Latest Turn Therapeutics' Research Development Growth Pattern

Below is the plot of the Research Development of Turn Therapeutics Common over the last few years. It is Turn Therapeutics' Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Turn Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Turn Research Development Regression Statistics

Arithmetic Mean54,753
Geometric Mean14,156
Coefficient Of Variation192.92
Mean Deviation77,828
Median7,500
Standard Deviation105,631
Sample Variance11.2B
Range289.5K
R-Value0.66
Mean Square Error6.6B
R-Squared0.44
Significance0
Slope13,907
Total Sum of Squares178.5B

Turn Research Development History

2026297 K
2025282.8 K
2024246 K

About Turn Therapeutics Financial Statements

Turn Therapeutics investors use historical fundamental indicators, such as Turn Therapeutics' Research Development, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Turn Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development282.8 K297 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Turn Stock Analysis

When running Turn Therapeutics' price analysis, check to measure Turn Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Turn Therapeutics is operating at the current time. Most of Turn Therapeutics' value examination focuses on studying past and present price action to predict the probability of Turn Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Turn Therapeutics' price. Additionally, you may evaluate how the addition of Turn Therapeutics to your portfolios can decrease your overall portfolio volatility.